|Bid||0.4000 x 800|
|Ask||0.8000 x 1100|
|Day's Range||0.5150 - 0.5651|
|52 Week Range||0.4500 - 2.3900|
|Beta (3Y Monthly)||1.13|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 8, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||1.90|
NantHealth, Inc. (NH) delivered earnings and revenue surprises of 55.56% and 7.03%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
CULVER CITY, Calif.-- -- Q2 Financial Highlights: Fourth consecutive quarter of total revenue growth Total revenue was $25.7 million, up 17% from Q2 2018 SaaS revenue of $18.3 million, rose 13% from Q2 2018 and 3% sequentially Gross profit was $15.9 million, compared with $11.5 million in Q2 2018 Gross margin increased to 62% from 52% in Q2 2018 Software and Service business continued positive momentum ...
NantHealth, Inc. (NH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
If you want to know who really controls NantHealth, Inc. (NASDAQ:NH), then you'll have to look at the makeup of its...
NantHealth to Showcase Advancements in Technology that Enable Value-Based Care and Discuss Technology's Role in Reducing Health Care Costs
NantHealth Inc NASDAQ/NGS:NHView full report here! Summary * ETFs holding this stock are seeing positive inflows * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is low for NH with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | PositiveETF activity is positive. Over the last month, growth of ETFs holding NH is favorable, with net inflows of $1.22 billion. This is among the highest net inflows seen over the last one-year and the rate of additional inflows appears to be increasing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to email@example.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
NantHealth, Inc. , a next-generation, evidence-based, personalized healthcare company, today announced its partnership with CareSource, a leading nonprofit multi-state health plan serving government-sponsored programs, to bring patients value-based care through Eviti® Connect, the evidence-based treatment intelligence and web-based oncology decision support platform.
NantHealth, Inc. (NH), a next-generation, evidence-based, personalized health care company, will be exhibiting innovative connected solutions at the 2019 HIMSS and Health 2.0 European Conference, scheduled for June 11-13, in Helsinki, Finland. This event convenes over 2,000 participants and exhibiting companies from across 60 countries, promising to make the event the most influential digital health conference in Europe this year. At the conference, NantHealth will be at booth 6g10c in the first-ever U.S. Pavilion, hosted by HIMSS and the U.S. Commercial Service, to showcase their Connected Care product line to Europe’s eHealth decision-makers.
Collaborative Efforts with Clients and Partners are Key for Making the Digital Disruption in Health Care a Reality
Results to be presented during the cancer prevention, hereditary genetics and epidemiology session at the ASCO 2019 Annual Meeting
New Enhancements Advance Medical Device Interoperability and Clinician Productivity; Two Critical Components for Reducing Errors and Streamlining Processes within Health Care Netwo
Members of the NantHealth Connected Care Team to Participate in Several Presentations Regarding Medical Device Integration and Interoperability
CULVER CITY, Calif.-- -- Total revenue in Q1 was $23.7 million, up 7% from Q1 2018 SaaS revenue of $17.8 million in Q1, up 10% from Q1 2018 and 3% sequentially Signed Substantial Three-year Eviti Contract with Multi-state Healthcare Payer Sequencing and Molecular Analysis, 820 total tests ordered in Q1, including 428 GPS Cancer® and 392 Liquid GPS SM Tests NantHealth, Inc. , a next-generation, evidence-based, ...
NantHealth, Inc. , a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2019 first quarter on Thursday, May 9, 2019, after market close.
NantHealth, Inc. , a next-generation, evidence-based, personalized healthcare company, will present on Connected Care VitalsConX technology at the American Nursing Informatics Association Annual Conference taking place April 12-13, 2019 at the Rio All Suite Hotel & Casino in Las Vegas, NV in booth #213.
CULVER CITY, Calif.-- -- Total Revenue in Q4 was $22.9 Million SaaS revenue of $17.3 million in Q4, up 9% from Q3 Enhanced efficiencies continued to drive significantly lower operating expenses in both Q4 and full year of 2018 For 2018, substantially improved adjusted Non-GAAP bottom line results Sequencing and Molecular Analysis, 1,021 total tests ordered in Q4, including 539 GPS Cancer® and 482 Liquid ...
NEW YORK, NY / ACCESSWIRE / March 28, 2019 / NantHealth, Inc. (NASDAQ: NH ) will be discussing their earnings results in their 2018 Fourth Quarter Earnings to be held on March 28, 2019 at 4:30 PM Eastern ...